Form 8-K Edwards Lifesciences For: Feb 03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Edwards Lifesciences (EW) Estimates Raised at Jefferies Following 'Stellar' Q4
February 4, 2015 8:43 AM ESTJefferies analyst Raj Denhoy reiterated a Buy rating and $155 price target on Edwards Lifesciences (NYSE: EW) while raising estimates following strong q4 results.
Denhoy commented, "EW posted a stellar 4Q, highlighted by (1) robust TAVR performance across geographies, particularly EU, despite increasing competitionand the... More
